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“OBSERVATIONS ON LIPID METABOLISM”
R. B. L. EWART, B.Sc., M.B., Ch.B., Senior President 1963-64.
Based on a Dissertation presented  to the Society on 25th O ctober, 1963.
Prior to 1936, it was the custom to regard 
adipose tissue of an accumulation of inert lipid 
material, possessing little or 110 m etabolic 
activity, but, in that year, this viewpoint was 
challenged by the work of Schoenheim er and 
R ittenberg. On the basis of measurements of 
the rate of disappearance of labelled fatty acids 
from the body of the mouse, these workers 
concluded that the half-life of the total fatty 
acids in this anim al, under the conditions of 
the experim ent, was of the order of three days. 
Since the depots constitute by far the greatest 
part of the body fats, it was assumed that the 
turnover rate observed was that characteristic 
of the depot fat. T h e  acceptance of these 
results necessitated the im m ediate rejection of 
the long cherished idea that adipose tissue 
represents an inert lipid store, capable of change 
only during periods of fasting or of excess in­
gestion of food.
T h is “ about face”  in belief naturally stim u­
lated m any workers and confirmatory results 
appeared rapidly in the literature. Thus, 
Shapiro and W ertheim er evaluated the oxygen 
uptake of adipose tissue in vitro  and took the 
elem entary precaution, or so it appears now, of 
expressing their results in terms of the fat-free 
weight of the tissue in this way demonstrating 
that “ depot fat”  (so-called) ranked amongst 
the most active tissues in the body when judged 
by this criterion. In 1942, T u erkischer and 
W ertheim er reported that all dietary regimens 
which enhance fat formation also give rise to 
the deposition of glycogen within the adipose 
tissue cells. Furtherm ore, these authors pointed 
out that this accumulation of polysaccharide is 
associated with high respiratory quotients, often
exceeding unity, indicating that active fat syn­
thesis is occurring. M ore recently, isotopic 
evidence of fat synthesis in adipose tissue in 
vivo  has been obtained by Fararger and G erlach 
who found that the fatty acids of rat mesenteric 
lipid have higher specific activities than those 
of either liver or blood shortly after the injec­
tion of radioactive acetate or glucose.
Isolated enzymes of adipose tissue have, to 
date, been studied relatively little but it may 
be assumed, from the fact that the tissue is cap­
able of perform ing such reaction sequences as 
those involved in respiration and fat and glyco­
gen syntheses that m any enzyme systems do 
occur in this tissue. There is nothing to be 
gained by further discussion of these systems 
here— suffice it to say that the main point estab­
lished by the endeavours to demonstrate 
enzymic activities in adipose tissue is its evident 
marked specialisation in terms of lipid m etabol­
ism. W h ile  most of those enzymes sought can 
be detected in this tissue, those concerned with 
fat m etabolism show an activity equal to or 
exceeding that of their counterparts in the most 
active tissues of the body.
For m any years reports appeared sporadically 
in the literature of small amounts of 11011- 
esterified fatty acid (N efa) which can be de­
tected in plasma, but until the early 1950 ’s this 
lipid fraction was widely regarded as an artefact 
of isolation. A t this time, however, Gordon 
pointed out that certain observed “ anom alies” 
in the electrophoretic m obility of plasma pro­
teins may be reproduced in vitro  by the addi­
tion of sodium oleate to plasma prior to the 
application of the separatory procedure. This
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provided the first d ue leading to the suggestion 
that N efa m ight be a physiological component 
o f the circulating lipids, bu t i t  was not u n til a 
year had elapsed that Gordon and Cherkes 
ascribed to this fraction an im portan t role in 
the transport o f fats from  the depots to the 
tissues fo r oxidation. Th is contention is sup­
ported by several lines o f evidence. First, i t  
has been shown that N efa injected in to  various 
experimental animals has a circulating half-life 
of the order of only two minutes, indicating 
its rapid removal from the blood. Second, 
estimates made of the arterio-venous differences 
in plasma N efa levels across various organs have 
indicated that, fo r example, the myocardium of 
the fasted animal is capable of removing 0.3 
M Equivalents of N efa from  each litre  of the 
perfusing blood. In  order to assess the physio­
logical significance o f this process, the authors 
performed concurrent measurements of oxygen 
uptake and, 011 the basis of the assumption that 
the average molecular weight of the fatty acid 
taken up is 275 (i.e. a m ixture of fa tty  acids 
quantita tive ly distributed about the hypotheti­
cal C17 compound), they arrived at the con­
clusion that the quantity of N efa taken up by 
the heart if  sufficient to  provide the bu lk  of its 
energy requirement under the conditions of 
the experiment.
The next problem requiring explanation was 
the mechanism by which the constancy o f the 
arterial N efa level is maintained, a problem 
to which we shall return later. A t this moment, 
all that need be said is that all the tissues 
studied, including liver, appeared, on the basis 
of a rterio-venous difference studies, to be active 
in the extraction of N efa from  the circulating 
fluid. The quest, therefore, was fo r a source 
of N efa and the investigators turned to the 
adipose depots. They were no t disappointed 
for i t  was found that samples of blood from  the 
long saphenous vein, which may be regarded as 
draining the adipose tissue o f the lower lim b 
almost exclusively, showed large negative arte­
riovenous differences indicative of Nefa release.
Thus the pattern has emerged in which Nefa 
represents an im portant, readily available source 
of oxidizable material whose concentration in 
the blood is the resultant of its rate of removal 
by the tissues and the rate of its liberation from 
the fa t depots.
W e  may now turn our attention to a con­
sideration of the concept of “ caloric homeo­
stasis” . As was noted earlier, the concentration 
of N efa in  the plasma is maintained at a re­
latively constant level, between the lim its  0-5—
1 mEq per litre , despite the high rate of re­
moval by the tissues which is observed in the 
post absorptive state. Th is implies the opera­
tion of some fa irly  sensitive contro l mechanism 
capable of relating the rate of liberation of N efa 
to the somatic requirement. I f  we return for 
a m om ent to the work of Gordon and Cherkes 
in which the rate o f uptake of Nefa by the 
myocardium was estimated, we find that their 
results apply only to the fasting state. In  fact, 
Gordon proceeded in 1957 to repeat the ex­
periments and obtained sequential blood 
samples for the measurement of arterio-venous 
Nefa differences before, and for some tim e 
after, the adm inistration o f 100 g. of glucose 
together w ith  0.1 u n it o f insulin per Kg. of 
body weight to human subjects. In  this way 
he confirmed the previously obtained results 
and, in addition, showed that the ready avail­
ab ility  of glucose, which may be regarded as a 
preferred metabolite, abolishes no t only the 
uptake of N efa by the myocardium but also 
its liberation by the adipose tissue. Th is work 
provides an extremely elegant example of the 
close correlation existing between those pro­
cesses leading to the removal of fa tty  acids from 
the circulating fluids and those leading to their 
m obilization from  the fa t stores. In  general, i t  
may be said tha t all o f those factors which in ­
crease the u tiliza tion  o f glucose, decrease the 
outflow  of Nefa from the lip id  depots. An 
ingenious explanation of this phenomenon w ill 
be quoted elsewhere in this dissertation but, 
at present, i t  w ill suffice to remark that the 
m obilization of fat shows marked dependence 
on the state of nu tr itio n , and that pre-eminent 
in this regard is the status of carbohydrate 
metabolism.
W e  have seen, then, that adipose tissue ap­
pears to exert its influence on lip id  metabolism 
by adjusting the availability o f Nefa in accord­
ance w ith  somatic requirements fo r an oxidis- 
able substrate. Th is  being accepted the central 
issue quite clearly becomes that o f the elucida­
tion o f the nature o f the mechanism by which 
the adjustment is effected under physiological 
conditions. I t  would be logical to suppose that 
the process is subject to humoral and to nervous 
control and indeed, evidence that such is the 
case has been obtained by many investigators.
The first piece of evidence regarding the role 
of nervous activ ity was provided in 1922 by 
G oering who pointed out that excessive nerve 
stim ulation provokes fa t loss from  the adipose 
tissue situated w ith in  the d istribution of the 
affected nerve, whereas paralysis or nerve
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section results in a marked deposition of fat in 
the depots, the magnitude of which may be 
partially or totally masked by the associated 
atrophy of the somatic musculature. Then, in 
1947, Clement reported that unilateral denerva­
tion of various fat bodies in the rat caused a 
diminution in the rate of depletion of trigly­
ceride from the denervated side during fasting. 
Such observations suggest that the nervous 
system may exercise a tonic effect upon Nefa 
liberation from fat depots. This concept has 
found confirmation in the work of Havel and 
Gotofen (1960) who investigated the role of 
the sympathetic nervous system in the metabol­
ism of free fatty acids and observed that admin­
istration of hexamethonium, a ganglion block­
ing agent, causes a reduction in plasma Nefa 
levels in the fasting dog. From observations 
such as these, it has been concluded that the 
sympathetic nervous system exercises a tonic 
influence on the adipose tissue which may pro­
vide for a continuous release of Nefa at a level 
which can be modified by insulin and other 
Immoral agents. In addition to this, variation 
in the intensity of sympathetic activity itself 
might be reasonably expected to exert a direct 
effect on lipid mobilization.
Many humoral agents have been implicated 
in the regulation of fatty acid exchange in 
adipose tissue. We may begin by considering 
epinephrine. Administration of this hormone 
to fasting humans has been found consistently 
to give rise to very rapid and striking increases 
in the plasma Nefa content which can be 
attributed to an increased rate of mobilization 
from the fat depots (as shown by arterio-venous 
difference studies) (Gordon and Cherkes, 
1956). In 1957, Wadstrom observed that 90 
minutes after the injection of 0.01 mg. of 
epinephrine into rabbits there is a decrease in 
the triglycende content of the fat depots asso­
ciated with corresponding increases in the 
levels of glycerol, mono and di-glycerides. This 
evidence pointed to the conclusion that epine­
phrine activates lipolysis or, what amounts to 
the same thing, inhibits resynthesis of trigly­
ceride in the adipose tissue. More recently, it 
has been shown by Gordon and Cherkes (1958) 
that the addition of epinephrine to surviving 
adipose tissue, in vitro, accelerates the rate at 
which this tissue releases Nefa into the sur­
rounding medium.
Shafir et al. have pointed out two interesting 
facts in relation to the effect of epinephrine on 
lipid metabolism. In the first place they
observed that this hormone gives rise to 
parallel increases of Nefa and lipiprotein 
which latter plasma constituent is, in all 
probability, formed by the liver in response to 
the increased availability of fatty acids. The 
second, and perhaps the more intriguing, obser­
vation made by this group is that epinephrine 
exerts a more rapid effect upon lipid than on 
carbohydrate metabolism. Thus it  is found 
that the hormone gives rise to a primary 
elevation of Nefa levels in plasma which gradu­
ally return to normal as the blood glucose rises. 
This observation is in agreement with the 
earlier results obtained by the same group in 
1959 which indicated that the Nefa response to 
epinephrine can be prevented by simultaneous 
administration of glucose and insulin. The 
observation finds confirmation also in the work 
of Goldfen and Havel which showed that the 
Nefa response to norepinephrine, administra­
tion of which does not lead to marked hyper- 
glycacmia, is sustained for a much longer time 
than that produced by epinephrine itself. The 
interesting fact emerging from these results is 
simply that, in time of stress, it is the lipid 
stores on which the body depends as a primary 
source of energy.
The second endocrine organ which exercises 
a profound effect upon lipid mobilization from 
storage sites is the anterior lobe of the p itu it­
ary. Some four hormones of pituitary origin 
have been shown to exert control over fatty 
acid metabolism; these arc somatotrophin 
(growth hormone), thyrotrophic hormone 
(TSH), the corticotrophins (ACTH ) and 
prolactin. I t  should be emphasised that the 
effects of A C T II and TSH are of peculiar 
interest in this connection, since, on the basis 
of in vitro studies, it is known that their action 
is not dependent upon the presence of their 
“ target organs” , though, in the whole animal, 
the presence of these organs will modify the 
lipid response observed.
The evidence so far to hand suggests that 
all four hormones influence lipid metabolism 
in essentially the same way: somatotrophin, 
however, by a sort of historical accident, has 
been studied most intensely and so the effects 
of this hormone will be considered at greater 
length than those of the other three.
In 1944, Stetton and Salcedo, injected 
anterior pituitary extract into mice, a procedure 
known to give rise to a condition of “ fatty 
liver” : they discovered by means of prior 
deuterium labelling that the excess hepatic 
lipid had been transported to that organ from
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the adipose storage depots.
The problems involved in the isolation of 
pure and homogeneous preparations of the 
various p itu ita ry  principles made further pro­
gress in this field d ifficu lt and even today, 
render interpretation a m atter open to doubt. 
However, in 1953, Greenbaum and McLean 
reported that treatment o f rats w ith  “ purified”  
som atotrophin caused a very rapid increase in 
hepatic triglyceride content. In  view of the 
fact that the hormone is known to increase the 
rate of fa tty  acid oxidation in the liver, and 
bearing in m ind the results of Stetton and 
Salcedo above, it  seems apparent that the 
accumulation of lip id  material in the liver 
under these circumstances must result from an 
increased rate of transport of fa tty acids to this 
organ from the depot fat. T ha t som atotrophin 
can increase the rate of m obilization of Nefa 
from adipose tissue is further suggested by the 
finding that the plasma N efa level of fasting 
dogs, already high, may be readily increased 
two-fold by the in jection of “ purified”  bovine 
so m a to tro p in .
The in vivo evidence of a fat m obiliz ing 
action of so m a to tro p in  is thus fa irly clear cut, 
but unfortunately it  has so far proved impos­
sible to demonstrate this activ ity of the hor­
mone in vitro. In  1958, however, W h ite  and 
Lugel in experiments w ith  A C T H  showed that 
a) co rtico tro p in s  arc more active than soma- 
to troph in  in prom oting fatty acid liberation 
in vivo and b) that they also display a powerful 
effect in the case of adipose tissue in vitro. On 
the basis of these observations, W h ite  and 
Lugel proposed the possibility, which still 
awaits experimental verification, that soma- 
totrophin may be inactive in itself bu t that, in 
the intact animal, i t  may be metabolised to a 
product which is capable of prom oting fatty 
acid liberation from  the fat depots —  the 
analogy here to the case of L-thyroxinc is so 
obvious that no further comment is required.
The two remaining hormones, T S H and 
prolactin, arc not so well defined as regards 
their action on lip id  metabolism. For example, 
in v itro  experiments have indicated that T S H 
is capable of increasing the rate of N efa release 
from adipose tissue bu t only when present in 
unphysiologically high concentrations. The 
state of our knowledge concerning the action 
of prolactin on fatty acid metabolism is equally 
unsatisfactory. Reiss (1947) maintains that 
in jection of this hormone leads to well marked 
depletion of the fat stores, but, as in the case 
o f s o m a to tro p in , n o  in  vitro  activity  can be
demonstrated. On purely teleological grounds, 
Reiss proceeded to argue that i t  is logical to 
expect prolactin to exercise a fat mobilising 
effect, especially in view o f the fact that Shaw 
and Petersen (1938) have claimed, on the basis 
of A /V  lip id  differences across the lactating 
udder, that more than enough circulating lip id , 
in what form they do not say, is abstracted 
f rom the blood by this organ, to account for 
the entire lip id  content of the m ilk . This 
effect of prolactin was also claimed on the basis 
of H oussay’s observation that so m a to tro p in  
and the corticotrophins can, at least in part, 
replace prolactin in the maintenance of lacta­
tion in the hypophysectom ised animal. A  
warning must be given at this po in t concerning 
the valid ity of such “ round about”  arguments 
however, and the whole status of the re liab ility  
o f observations based upon work w ith  so 
called “ pure”  anterior p itu ita ry  principles must 
be examined critica lly before acceptance.
W e  may now pass on to a consideration of 
insulin. Both the concentration and turnover 
of Nefa in blood are strik ingly influenced by 
this hormone. In the normal fasting animal 
and in the diabetic animal, the circulating Nefa 
level is decidedly increased and indeed, in 
severe ketotic diabetes the molar ratio o f fa tty 
acid to scrum album in may exceed seven, which 
is the maximum number of fa tty  acid mole­
cules which can be tigh tly  bound by one mole­
cule o f serum album in, the normal value being 
rather less than one (Goodman and Gordon, 
1958).
In 1958 Dole observed that the administra­
tion of insulin causes a marked fa ll in the 
plasma Nefa level of normal individuals. As 
in the ease of epinephrine considered above, 
the action of insulin is o f particular interest in 
that this hormone has been shown (Dole 1958) 
to exercise an effect more rapidly on circulat­
ing lip id  than on blood glucose. Once again, 
this may be regarded as a reflection of the 
importance of lip id  metabolism in the liv ing 
animal.
In  addition to the in  vivo findings outlined 
earlier, C herkes and Gordon, in 1958, measured 
the rate of release of N efa by epididymal fat 
bodies obtained from fasting rats, when these 
adipose tissue fragments were incubated in a 
medium containing bovine serum album in as 
an acceptor of Nefa. I n the absence o f the 
hormone it  was found that the tissue release 
1.57 µ m of fatty acid per gram per hour while, 
w ith  the addition of physiological concentra-
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tion  o f insulin a net uptake o f Nefa from  the 
medium was observed, am ounting to 1.03 um 
per gram per hour. In  other words the tissue 
which was releasing Nefa, on the addition of 
insulin, was persuaded to take up N efa from 
the environment.
O ther hormones have been reported to 
m odify the metabolic activ ity  o f adipose tissue 
but the ir effects remain, in  general, poorly 
understood and in the interests o f brevity they 
w ill no t be discussed here.
W e  have seen, then, some of the ways in 
which the uptake and liberation o f fa tty  acids 
by adipose tissue may be controlled in vivo, bu t 
two very fundamental questions now present 
themselves. F irstly, what is the nature of the 
stimulus which causes the contro l m echanism 
to come in to  play and secondly, how is the 
neuro/hum oral in form ation translated in to  
terms of biochemical process? T o  neither of 
these questions, particularly the latter, can 
defin itive answers be given at this tim e bu t in 
what follows, some a ttem pt w ill be made to 
clarify the situation insofar as i t  is possible, 
presently, to do so.
I f  we consider the normal physiological 
situation obta in ing in an organism, then i t  is 
clear tha t the effect o f somatotrophin on lip id  
metabolism, in  the normal adult, may be 
assumed to be more or less negligible, though 
i t  may be significant in the young animal in 
which the provision o f adequate amounts of 
oxidisiable substrate to the growing tissue is 
mandatory. In  any event, i t  seems more like ly 
than no t that any physiological effect a ttr ib u t­
able to somatotrophin w ill be tonic in nature 
and not subject to rapid or marked fluctuation. 
O n the other hand, a ll o f the other compon­
ents of the contro l m echanism are capable of 
dynamic variation dependent on tissue require­
ments from  m om ent to mom ent. T im s, the 
m obilisation of N e fa  in response to sympath­
etic nervous stim ulation and to the release 
of epinephrine by the adrenal medulla is a 
biochemical reflection o f the sensitivity of the 
nervous system to various types o f stress, and is 
mediated by the activ ity of the higher nerve 
centres. Insu lin , which strongly inh ib its  liber­
ation o f N efa from  depot fat and, as we have 
seen, may actually prom ote fa tty  acid uptake 
by adipose tissue, is liberated from  the pancreas 
in response to the stimulus o f high blood sugar 
levels acting directly upon the pancreatic cells. 
As I have said before, this provides an example 
of the close correlation existing between carbo­
hydrate and lip id  metabolism and explains the
observed dependence o f plasma N efa levels on 
the nu tritiona l state o f the animal. Thus, a 
fasting animal may be expected to have a low  
blood glucose level associated w ith  a high level 
o f circu lating N e fa  bu t i f  an alimentary hyper- 
glycacmia is established, the resulting increase 
in the level o f circu lating insulin may be held 
to explain the rapid fa ll in plasma N efa which 
is observed in such a situation.
The mechanism by which this final contro l 
is actually mediated is rather more obscure. 
Throughout this article, reference has 
been made to the lipo ly tic  activ ity  o f adipose 
tissue. T he  im p lica tion  has been that the 
various components of the neuro-humoral con­
tro l system m od ify  the activ ity  of tissue lipases. 
Clearly, however, an exactly parallel situation 
would arise if  contro l was exercised by m od ifi­
cations in the rate o f synthesis o f triglyceride 
w ith in  the adipose tissue cells.
Le t us examine these possibilities. F irst, the 
lipase hypothesis. Korn and Quigley found in 
1957 that the only lipase activ ity  demonstrable 
in many types o f adipose tissue was that due 
to heparin activated “ lipopro te in  lipase” . For 
this reason, a great, and perhaps d isproportion­
ate, num ber of investigators have studied the 
behaviour o f this enzyme in relation to fat 
m obiliza tion and deposition. Typical o f this 
field o f endeavour, is the work o f Hollenberg 
(1959) who reported tha t the addition of 
glucose and insulin to adipose tissue from  fast­
ing animals, restores the capacity o f the tissue, 
in v itro , to liberate “ lipoprote in  lipase”  in 
response to heparin. From this he concluded 
that the enzyme may be concerned in the 
accumulation o f fat in depots, possibly by 
influencing the rate of incorporation o f lipopro ­
tein fa tty  acids in to  adipose tissue cells. M any 
fu rther studies have been undertaken and, by 
and large, all im plicate lipoprote in lipase in 
the uptake o f fat, in the form  o f Nefa, by the 
depots.
W h a t then of N efa release: in this case the 
substrate is rather different— not lipoprote in as 
in plasma, bu t more or less pure neutral fat 
(triglyceride) a fact that appears to rule lipopro ­
tein lipase activ ity  out of court since the 
activ ity o f the enzyme toward pure triglyceride 
is vanishingly small. W e  must turn, then, to 
consideration of the second hypothesis, that 
dealing w ith  rates o f reeste r fication.
In  1 960, W ood et al. pointed out that in 
rat epididymal fa t tissue, glucose carbon is 
incorporated in to  the glycerol m oeity o f trigly- 
ceride at a rate many times greater than the
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carbon of glycerol itself: they went on to 
demonstrate that adipose tissue homogenates 
require. L-a-glycero-phosphate or one of its 
phosphorylated precursors for optimum esteri- 
fication of carbon labelled palmitate, glycerol 
itself being inactive in this system. If  this is 
equally true of intact adipose tissue, then 
esterification of Nefa should be limited by the 
rate of formation of L-a-glycero-phosphate from 
glucose via di-hydroxy-acetone-phosphate.
Now it is known that the triglyceride of 
adipose tissue undergoes constant hydrolysis 
ancl re - esterification within the tissue; 
by what mechanism the hydrolysis 
is effected is not understood. However, it must 
be assumed on this evidence that, in the steady 
state condition, where there is no net uptake 
on release of Nefa, the liberated fatty acids are 
rapidly re-esterified. This re-esterification re­
quires the presence of a supply of l-a-glycero- 
phosphate obtained by the metabolism of 
glucose via the Em bden-M eyerhof pathway. 
The equilibrium situation between triglyceride 
and Nefa within the cells is quite obviously 
dependant upon a ready supply of glucose. 
During periods of hypoglycaemia, the Nefa 
of the adipose tissue might be expected to rise 
and since intracellular and extracellular Nefa 
arc in a free translocation relationship this will 
lead to their liberation into the blood; con­
versely, after glucose and insulin administration 
the enhanced respiratory activity of the adipose 
tissue cells w ill ensure a plentiful supply of 
dihydroxy acetone phosphate and therefore of 
L-a-glycero-phosphate so that the fatty acid 
level of the circulating fluid will diminish as 
Nefa is withdrawn to be esterified within the 
cells.
This hypothesis has been found to accord 
well with experimental data in which the per­
centage of glucose carbon incorporated into 
the glycerol moiety of neutral fat has been 
estimated under varying conditions of availa­
bility of glucose. It provides an elegant ex­
ample of the indirect way in which hormonal 
substances may modify cell metabolism since 
the action of insulin on fatty acid mobilization 
appears in this way to be explicable in terms 
of a primary action of the hormone, notably 
that of influencing the translocation of glucose 
across cell membranes. Attractive though the 
hypothesis may be, however, a note of caution 
must be sounded— the energy transformations 
and relationships in systems such as this remain 
obscure, complicated as they are by the very 
peculiar solubility properties of the participat­
ing lipids and lipoproteins and estimations of 
equilibrium constants for such systems have 
not, so far, been attempted.
In this article a very few of the ad­
vances which have been made towards the 
understanding of adipose tissue and its role in 
lipid metabolism have been discussed. W e  
have considered the recognition, some thirty 
years ago, of the fat depots as dynamic entities, 
the discovery of the significance of Nefa in 
metabolism and the possible means by which 
the control of lipid uptake and release by 
adipose tissue may be affected under physiolo­
gical conditions.
W h at has emerged is still a far from coher­
ent story and we can only wait, perhaps for a 
further quarter of a century in the hope that 
the final word may yet be spoken.
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